>>> US Gapping up

Gapping up
In reaction to earnings/guidance:

DXCM +17.3% (also authorizes new $500 mln share repurchase program), COUR +10.4%, DECK +10.2%, CUBI +9.7%, EVTC +9.6%, MGRC +8.6%, APPF +7.7%, INTC +7.3%, NRDS +7.2% (also authorizes new $30 mln share repurchase program), TROW +6.7%, AMZN +6.6%, TBBK +6.1%, MMSI +5.5%, MTX +5.3%, COF +5.2%, BFST +5.1%, AVTR +5%, CPT +4.6%, MITK +4.4%, FIX +4.4% (also increases dividend), ATGE +4.3%, JNPR +4.2%, SKX +4%, CMG +3.8%, AER +3.8%, SWK +3.6%, AN +2.9%, ERIE +2.6%, EGO +2.5%, EMN +2.3%, OIS +2.2%, CDP +2%, MHK +2%, TARO +2%, LPLA +1.8%, DAR +1.8%, LHX +1.5%, EQNR +1.5%, X +1.3%, EHC +1.3%, LTC +1.2%, RMD +1.1%, CL +1.1%, SAIA +1%

Other news:

PRME +7.8% (Presents First-ever Prime Editing Data in Non-human Primates Demonstrating Highly Efficient Ability of Prime Editors to Precisely Correct Disease-causing Mutation of GSD1b)
MASI +7.7% (announces USITC issues exclusion order for infringing Apple Watches finding that Apple Violated U.S. trade laws)
GRPN +7% (Citadel files 13G disclosing 4.3% passive stake)
SWI +6.6% (exploring potential sale according to Bloomberg)
CBOE +3.3% (increases share repurchase auth by $250 mln)
SCU +1.7% (Rithm Capital (RITM) enters into amended merger agreement to acquire Sculptor Capital Management For $12.70 Per Sculptor Class A Share) BCRX +1.6% (to Present New ORLADEYO (berotralstat) Data at Annual Scientific Meeting of American College of Allergy Asthma & Immunology)
APO +1.4% (Apo to invest up to €1.5 bln into an Air France-KLM)
IMGN +1.4% (announces European Medicines Agency Acceptance of Marketing Authorization Application for mirvetuximab soravtansine (ELAHERE) in platinum-resistant ovarian cancer)
SHO +1.3% (completes sale of Boston Park Plaza for $370 mln)
GLUE +1.2% (raises $25 mln at-the-market from investor)
WSR +1% (Fortress interested in takeover of WSR according to Bloomberg)
PII +0.9% (authorizes new $1 bln share repurchase program)

Analyst comments: